Disruption of LDL but Not VLDL Clearance in Autosomal Recessive Hypercholesterolemia

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2007 Jan 4

PMID 17200716

Citations 27

Authors

Christopher Jones

Rita Garuti

Peter Michaely

Wei-Ping Li

Nobuyo Maeda

Jonathan C Cohen

Joachim Herz

Helen H Hobbs

Affiliations

Soon will be listed here.

Abstract

Genetic defects in LDL clearance result in severe hypercholesterolemia and premature atherosclerosis. Mutations in the LDL receptor (LDLR) cause familial hypercholesterolemia (FH), the most severe form of genetic hypercholesterolemia. A phenocopy of FH, autosomal recessive hypercholesterolemia (ARH), is due to mutations in an adaptor protein involved in LDLR internalization. Despite comparable reductions in LDL clearance rates, plasma LDL levels are substantially lower in ARH than in FH. To determine the metabolic basis for this difference, we examined the synthesis and catabolism of VLDL in murine models of FH (Ldlr(-/-)) and ARH (Arh(-/-)). The hyperlipidemic response to a high-sucrose diet was greatly attenuated in Arh(-/-) mice compared with Ldlr(-/-) mice despite similar rates of VLDL secretion. The rate of VLDL clearance was significantly higher in Arh(-/-) mice than in Ldlr(-/-) mice, suggesting that LDLR-dependent uptake of VLDL is maintained in the absence of ARH. Consistent with these findings, hepatocytes from Arh(-/-) mice (but not Ldlr(-/-) mice) internalized beta-migrating VLDL (beta-VLDL). These results demonstrate that ARH is not required for LDLR-dependent uptake of VLDL by the liver. The preservation of VLDL remnant clearance attenuates the phenotype of ARH and likely contributes to greater responsiveness to statins in ARH compared with FH.

Citing Articles

Glucagon receptor signaling at white adipose tissue does not regulate lipolysis.

Vasileva A, Marx T, Beaudry J, Stern J Am J Physiol Endocrinol Metab. 2022; 323(4):E389-E401.

PMID: 36002172 PMC: 9576180. DOI: 10.1152/ajpendo.00078.2022.

Deletion of LDLRAP1 Induces Atherosclerotic Plaque Formation, Insulin Resistance, and Dysregulated Insulin Response in Adipose Tissue.

Leigh T, Kawai T, Preston K, Kelemen S, Okune R, St Paul A Am J Pathol. 2022; 192(7):1092-1108.

PMID: 35460615 PMC: 9253916. DOI: 10.1016/j.ajpath.2022.03.014.

GALNT2 regulates ANGPTL3 cleavage in cells and in vivo of mice.

Li X, Zhang Y, Zhang M, Wang Y Sci Rep. 2020; 10(1):16168.

PMID: 32999434 PMC: 7527996. DOI: 10.1038/s41598-020-73388-3.

Science, serendipity, and the single degree.

Hobbs H J Clin Invest. 2018; 128(10):4218-4223.

PMID: 30272579 PMC: 6159963. DOI: 10.1172/JCI124404.

Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice.

Tao W, Moore R, Smith E, Xu X Front Cell Dev Biol. 2016; 4:129.

PMID: 27933291 PMC: 5122593. DOI: 10.3389/fcell.2016.00129.

References

Bolton A, Hunter W . The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J. 1973; 133(3):529-39. PMC: 1177731. DOI: 10.1042/bj1330529. View

Garuti R, Jones C, Li W, Michaely P, Herz J, Gerard R . The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits. J Biol Chem. 2005; 280(49):40996-1004. DOI: 10.1074/jbc.M509394200. View

Millar J, Maugeais C, Fuki I, Rader D . Normal production rate of apolipoprotein B in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2002; 22(6):989-94. DOI: 10.1161/01.atv.0000018304.30943.06. View

Butcher E, LOWRY O . Measurement of nanogram quantities of protein by hydrolysis followed by reaction with orthophthalaldehyde or determination of glutamate. Anal Biochem. 1976; 76(2):502-23. DOI: 10.1016/0003-2697(76)90343-2. View

Innerarity T, Mahley R . Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry. 1978; 17(8):1440-7. DOI: 10.1021/bi00601a013. View

Krieger M, Smith L, Anderson R, Goldstein J, Kao Y, Pownall H . Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells. J Supramol Struct. 1979; 10(4):467-78. DOI: 10.1002/jss.400100409. View

Pitas R, Innerarity T, Mahley R . Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein. J Biol Chem. 1980; 255(11):5454-60. View

Kovanen P, Brown M, Basu S, Bilheimer D, Goldstein J . Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proc Natl Acad Sci U S A. 1981; 78(3):1396-400. PMC: 319137. DOI: 10.1073/pnas.78.3.1396. View

Imber M, Pizzo S . Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin. J Biol Chem. 1981; 256(15):8134-9. View

10.

Pitas R, Innerarity T, Weinstein J, Mahley R . Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis. 1981; 1(3):177-85. DOI: 10.1161/01.atv.1.3.177. View

11.

Beisiegel U, Schneider W, Goldstein J, Anderson R, Brown M . Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. J Biol Chem. 1981; 256(22):11923-31. View

12.

Goldstein J, Basu S, Brown M . Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 1983; 98:241-60. DOI: 10.1016/0076-6879(83)98152-1. View

13.

Mahley R . Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988; 240(4852):622-30. DOI: 10.1126/science.3283935. View

14.

Pathak R, Yokode M, Hammer R, Hofmann S, Brown M, Goldstein J . Tissue-specific sorting of the human LDL receptor in polarized epithelia of transgenic mice. J Cell Biol. 1990; 111(2):347-59. PMC: 2116187. DOI: 10.1083/jcb.111.2.347. View

15.

Tabas I, Lim S, Xu X, Maxfield F . Endocytosed beta-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages. J Cell Biol. 1990; 111(3):929-40. PMC: 2116271. DOI: 10.1083/jcb.111.3.929. View

16.

Yokode M, Hammer R, Ishibashi S, Brown M, Goldstein J . Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors. Science. 1990; 250(4985):1273-5. DOI: 10.1126/science.2244210. View

17.

Corsini A, Mazzotti M, Villa A, Maggi F, Bernini F, Romano L . Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100. Atherosclerosis. 1992; 93(1-2):95-103. DOI: 10.1016/0021-9150(92)90203-s. View

18.

Harada-Shiba M, Tajima S, Yokoyama S, Miyake Y, Kojima S, Tsushima M . Siblings with normal LDL receptor activity and severe hypercholesterolemia. Arterioscler Thromb. 1992; 12(9):1071-8. DOI: 10.1161/01.atv.12.9.1071. View

19.

Choi S, Cooper A . A comparison of the roles of the low density lipoprotein (LDL) receptor and the LDL receptor-related protein/alpha 2-macroglobulin receptor in chylomicron remnant removal in the mouse in vivo. J Biol Chem. 1993; 268(21):15804-11. View

20.

Ishibashi S, Brown M, Goldstein J, Gerard R, Hammer R, Herz J . Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1993; 92(2):883-93. PMC: 294927. DOI: 10.1172/JCI116663. View